Evidence map›Paper›PMID 31182576›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Transfer of complex regional pain syndrome to mice via human autoantibodies is mediated by interleukin-1-induced mechanisms.

Zsuzsanna Helyes, Valéria Tékus, Nikolett Szentes, Krisztina Pohóczky, Bálint Botz, Tamás Kiss, Ágnes Kemény, Zsuzsanna Környei, Krisztina Tóth, Nikolett Lénárt and 6 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 66 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 2 pooled it
16.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 2 syntheses or guidelines pooled it, 118 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Recent advances in autoantibody-mediated pain.Current opinion in supportive and palliative care · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Autoantibodies as drivers of neuropathic pain.Trends in molecular medicine · 2026
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. [Biomarkers in complex regional pain syndrome].Schmerz (Berlin, Germany) · 2025
    Review
  17. Review
  18. Review
  19. Article
  20. Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 2 countries.

Zsuzsanna HelyesDepartment of Pharmacology and Pharmacotherapy, Medical School, University of Pécs, H-7624, Pécs, Hungary.
Valéria TékusDepartment of Pharmacology and Pharmacotherapy, Medical School, University of Pécs, H-7624, Pécs, Hungary.
Nikolett SzentesDepartment of Pharmacology and Pharmacotherapy, Medical School, University of Pécs, H-7624, Pécs, Hungary.
Krisztina PohóczkyDepartment of Pharmacology and Pharmacotherapy, Medical School, University of Pécs, H-7624, Pécs, Hungary.ORCID 0000-0003-0385-5162
Bálint BotzDepartment of Pharmacology and Pharmacotherapy, Medical School, University of Pécs, H-7624, Pécs, Hungary.
Tamás KissDepartment of Pharmacology and Pharmacotherapy, Medical School, University of Pécs, H-7624, Pécs, Hungary.
Ágnes KeményDepartment of Pharmacology and Pharmacotherapy, Medical School, University of Pécs, H-7624, Pécs, Hungary.
Zsuzsanna KörnyeiMomentum Laboratory of Neuroimmunology, Institute of Experimental Medicine, H-1083, Budapest, Hungary.
Krisztina TóthMomentum Laboratory of Neuroimmunology, Institute of Experimental Medicine, H-1083, Budapest, Hungary.ORCID 0000-0001-7926-2983
Nikolett LénártMomentum Laboratory of Neuroimmunology, Institute of Experimental Medicine, H-1083, Budapest, Hungary.ORCID 0000-0002-7456-949X
Hajnalka ÁbrahámDepartment of Biology and Electron Microscopy, Medical School, University of Pécs, H-7624, Pécs, Hungary.
Emmanuel PinteauxDivision of Neuroscience and Experimental Psychology, University of Manchester, Manchester M13 9PT, United Kingdom.
Sheila FrancisDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield S10 2RX, United Kingdom.
Serena SensiDepartment of Translational Medicine, University of Liverpool, Liverpool L9 7AL, United Kingdom.
Ádám DénesMomentum Laboratory of Neuroimmunology, Institute of Experimental Medicine, H-1083, Budapest, Hungary.
Andreas GoebelDepartment of Translational Medicine, University of Liverpool, Liverpool L9 7AL, United Kingdom.ORCID 0000-0002-3763-8206
University of Pecs · HUHUN-REN Institute of Experimental Medicine · HUUniversity of Manchester · GBNational Health Service · GBUniversity of Liverpool · GBUniversity of Sheffield · GB

Funding

British Heart Foundation PG/13/55/30365
6 · The paper itself

Abstract

Neuroimmune interactions may contribute to severe pain and regional inflammatory and autonomic signs in complex regional pain syndrome (CRPS), a posttraumatic pain disorder. Here, we investigated peripheral and central immune mechanisms in a translational passive transfer trauma mouse model of CRPS. Small plantar skin-muscle incision was performed in female C57BL/6 mice treated daily with purified serum immunoglobulin G (IgG) from patients with longstanding CRPS or healthy volunteers followed by assessment of paw edema, hyperalgesia, inflammation, and central glial activation. CRPS IgG significantly increased and prolonged swelling and induced stable hyperalgesia of the incised paw compared with IgG from healthy controls. After a short-lasting paw inflammatory response in all groups, CRPS IgG-injected mice displayed sustained, profound microglia and astrocyte activation in the dorsal horn of the spinal cord and pain-related brain regions, indicating central sensitization. Genetic deletion of interleukin-1 (IL-1) using IL-1αβ knockout (KO) mice and perioperative IL-1 receptor type 1 (IL-1R1) blockade with the drug anakinra, but not treatment with the glucocorticoid prednisolone, prevented these changes. Anakinra treatment also reversed the established sensitization phenotype when initiated 8 days after incision. Furthermore, with the generation of an IL-1β floxed

Indexed as

AdultAnimalsAutoantibodiesComplex Regional Pain SyndromesDisease Models, AnimalFemaleHumansImmunoglobulin GInterleukin-1alphaInterleukin-1betaInterleukin 1 Receptor Antagonist ProteinLower ExtremityMaleMiceMice, Inbred C57BLMice, KnockoutAutoantibodiesIL1B protein, mouseIL1R1 protein, mouseImmunoglobulin GInterleukin-1alphaInterleukin-1betaInterleukin 1 Receptor Antagonist ProteinReceptors, Interleukin-1 Type Ianakinraautoantibodycomplex regional pain syndromeCRPSinterleukin-1

Identifiers

PMID31182576
PMCPMC6600930
OpenAlexW2953088960

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.